| 2 min read
The brain and cerebral vasculature are notoriously difficult to access – is OCT the key to the door?
Mouse vision is presumed to have low spatial resolution – but the discovery of the focea begs to differ
Alzheimer’s research should benefit all, regardless of ethnicity or race
Blood biomarkers specific to brain damage may help identify early signs of stroke
Can genomic medicine usher in a new era of curative treatments for neurological diseases? Experts from Sangamo give their views
Phf21b, a protein associated with intellectual disability and depression, plays a crucial role in neurogenesis.
AstraZeneca's George Kirk tells us the story of Koselugo – a treatment for the rare genetic condition neurofibromatosis 1.
How can we encourage companies to pursue clinical research for CNS disorders?
Allen C. Ho,
Carl D. Regillo
Cutting-edge translational retina research for patients in Philadelphia and around the world
"Biogen revitalizes hope for Alzheimer’s therapy, but their work highlights why we still need greater selectivity."
Register to access our FREE online portfolio, request the magazine in print and
manage your preferences.
You will benefit from:
Express Insight into Bladder Cancer
Changing the Leopard’s Spots
Making It (Im)personal